A protocol to manage malignant hyperthermia with general anesthesia.
Roberts
M W
MW
Department of Pediatric Dentistry, School of Dentistry, University of North Carolina, Chapel Hill.
D000766:Anesthesia, Dental / Q000379:methods*; D000768:Anesthesia, General / Q000379:methods*; D015415:Biomarkers; D002675:Child, Preschool; D002985:Clinical Protocols; D000075202:Contraindications; D003402:Creatine Kinase / Q000097:blood; D003521:Cyclopropanes; D003620:Dantrolene; D011756:Diphosphates / Q000097:blood; D004737:Enflurane; D004986:Ether; D005260:Female; D005283:Fentanyl; D006221:Halothane; D006801:Humans; D008305:Malignant Hyperthermia / Q000517:prevention & control*; D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine; D014673:Vecuronium Bromide / Q000627:therapeutic use
D015415:Biomarkers; D003521:Cyclopropanes; D011756:Diphosphates; D009467:Neuromuscular Depolarizing Agents; D004986:Ether; D014673:Vecuronium Bromide; D004737:Enflurane; D003402:Creatine Kinase; D003620:Dantrolene; D013390:Succinylcholine; D005283:Fentanyl; D006221:Halothane